Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. (Q47854545)

6 February 2018

title

Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. (English)

1 reference

6 February 2018

1 reference

1 reference

Terryberry JW

1

1 reference

6 February 2018

Thor G

series ordinal

2

1 reference

6 February 2018

Peter JB

series ordinal

3

1 reference

6 February 2018

publication date

1 May 1998

1 reference

6 February 2018

published in

Neurobiology of Aging

1 reference

6 February 2018

volume

19

1 reference

6 February 2018

page(s)

205-216

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Inflammatory response in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Senile dementia, Alzheimer type: a distinct entity in the immunosenescence?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Association of polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serum and CSF immunological findings in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Characterization of antineurofilament autoantibodies in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serum antibodies to neurofilament antigens in patients with neurological and other diseases and in healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Specificity of human anti-neurofilament autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antibodies to tubulin and microtubule-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibodies against H- and M-subunits of neurofilaments are induced by PC12 cell grafts or lesions into different sites of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Nervous system lupus: pathogenesis and rationale for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Detection of autoantibodies to neural antigens in the CSF of Japanese encephalitis patients and correlation of findings with the outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Activation of protein kinase C induces neurofilament fragmentation, hyperphosphorylation of perikaryal neurofilaments and proximal dendritic swellings in cultured motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antineurofilament antibodies in postencephalitic and idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer's disease: detection of highly mutated V regions in both heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

gamma delta+ T cells are increased in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Animal models of age-related dementia: neurobehavioral dysfunctions in autoimmune mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antibodies to neurofilament protein in retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody-producing cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Amyloid precursor protein (APP) expression in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Evaluation of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Neuronal targets of serum and cerebrospinal fluid autoantibodies in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immune ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serine proteases and their serpin inhibitors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Binding of IgG to amyloid beta A4 peptide via the heavy-chain hinge region with preservation of antigen binding

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Inhibition of axonal transport 'in vivo' by a tubulin-specific antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

A monoclonal thymocytotoxic autoantibody from autoimmune-disease-prone New Zealand black mouse recognizes beta-tubulin in neural tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Anti-neurofilament antibodies in blood of patients with neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibodies to band 3 during aging and disease and aging interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serum IgG brain reactive antibodies in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immunohistochemical staining of senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Myasthenia gravis-associated thymic epithelial tumors express neurofilaments and are associated with antiaxonal autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Altered blood-brain-barrier function in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Pathological proteins in senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Cerebrospinal fluid microglial antibodies: potential diagnostic markers for immune mechanisms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Threshold analysis using diagnostic tests with multiple results.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immune reactivity in aging-autologous mixed lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibodies to retinal astrocytes associated with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Altered antigen expression of microglia in the aged rodent CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Anti-tubulin antibodies in recent onset type 1 (insulin-dependent) diabetes mellitus: comparison with islet cell antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Neurobehavioral alterations in autoimmune mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

The spectrum of neurologic disease associated with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Astrocytes, brain aging, and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Neuroanatomical anomalies in autoimmune mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Studies of neuroimmune markers in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Neuroautoimmunity: pathogenic implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Senile dementia of Alzheimer's type (SDAT): reduced T8+-cell-mediated suppressor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoantibodies against axonal neurofilaments in patients with Kuru and Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Myelin- and microbe-specific antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

T-lymphocyte function in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

The basis of intra-blood-brain-barrier IgG synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Immune-mediated oligodendrocyte injury

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Boundaries and wounds, glia and glycoconjugates. Cellular and molecular analyses of developmental partitions and adult brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

MHC class II-positive microglia in human brain: association with Alzheimer lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900049-9

7 January 2021

10.1016/S0197-4580(98)00049-9

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9661995

1 reference

6 February 2018